Skip to content
Annika Bansal – Lifestyle
Author:
Ensysce Biosciences
Ensysce Biosciences Announces Acquisition of Cy Biopharma and up to $77 Million Private Financing
August 6, 2026
EQPT Investors Have Opportunity to Lead EquipmentShare.com Inc Securities Lawsuit
August 6, 2026
BZAI Investors Have Opportunity to Lead Blaize Holdings, Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm
August 4, 2026
Ensysce Biosciences Awarded $5.3 Million Installment in NIDA Funding Completing Multi-Year $15 Million Federal Grant
July 14, 2026
Ensysce Biosciences Enrolls First Patient in Final Phase of PF614-MPAR-102 Clinical Study
June 26, 2026
VRRM Investors Have Opportunity to Lead Verra Mobility Corporation Securities Fraud Lawsuit
June 8, 2026
Ensysce Biosciences Reports First Quarter 2026 Financial Results
May 15, 2026
Ensysce Biosciences Announces Expansion of Patent Protection for Groundbreaking MPAR(R) Overdose Protection Technology
May 12, 2026
Ensysce Biosciences CEO Presents at Inaugural Clinical Pain Symposium in Amsterdam
May 8, 2026
Ensysce Biosciences Secures IRB Approval of Final Phase of PF614-MPAR-102 Clinical Study
April 16, 2026
1
2
Next Page
→